ConductScience.org, home

Library / Genes

CYP2C19: cytochrome P450 family 2 subfamily C member 19

1 protein, 26 patents, 0 drugs, 0 trials, 3,385 NIH grants and 15,778 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCYP2C19HGNC
Namecytochrome P450 family 2 subfamily C member 19HGNC
NCBI Gene ID1557NCBI Gene
HGNC IDHGNC:2621HGNC
EnsemblENSG00000165841NCBI Gene
AliasesCPCJ, CYP2C, CYPIIC17, CYPIIC19, P450C2C, P450IIC19NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P33261Cytochrome P450 2C194901Ensembl, GeneID, HGNCUniProt

Patents 26

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-198928P33261Espacenet
EP 4641201 A22025-10-299180P33261Espacenet
JP 2025147176 A2025-10-063868P33261Espacenet
JP 2025517969 A2025-06-129180P33261Espacenet
JP 2025517970 A2025-06-128928P33261Espacenet
JP 2025028160 A2025-02-283868P33261Espacenet
KR 1020250010750 A2025-01-213868P33261Espacenet
JP 2024109657 A2024-08-143875P33261Espacenet
US 11446398 B22022-09-2021929P33261Espacenet
JP 2022524081 A2022-04-27124900P33261Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3385

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA021765Cancer Center Support Grant (CCSG)412,025NIH's project files
K24HL133373Discovery, Implementation and Mentorship in Personalized Cardiovascular Pharmacotherapy222,025NIH's project files
U24HG010615PharmGKB212,025NIH's project files
T32GM008425Indiana University Comprehensive Training in Clinical Pharmacology202,025NIH's project files
P30DK056338Texas Medical Center Digestive Diseases Center182,025NIH's project files
P30CA008748Cancer Center Support Grant152,025NIH's project files
U01HG006379EHR-based Genomic Discovery and Implementation [Funded Extension]152,025NIH's project files
U54MD007600Center for Collaborative Research in Health Disparities142,025NIH's project files
T32HD069038Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology132,025NIH's project files
UL1TR002243Vanderbilt Institute for Clinical and Translational Research (VICTR)132,025NIH's project files

Papers 15778

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42826334PubTator, text miningPubMed
42822087PubTator, text miningPubMed
42820662PubTator, text miningPubMed
42811266PubTator, text miningPubMed
42808920PubTator, text miningPubMed
42808443PubTator, text miningPubMed
42807560PubTator, text miningPubMed
42804994PubTator, text miningPubMed
42800502PubTator, text miningPubMed
42797477PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license